Cuneyd Gunay

Prof. Dr. Cuneyd Gunay

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2010 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
CGCuneyd Gunay
Cuneyd Gunay
HAHakan Atalar
Hakan Atalar
YYYusuf Yildiz
Yusuf Yildiz
YSYener Saglik
Yener Saglik

31 March 2016 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
EAErtugrul Aksahin
Ertugrul Aksahin
CACem Nuri Aktekin
Cem Nuri Aktekin
OKOnur Kocadal
Onur Kocadal
SDSemra Duran
Semra Duran
CGCuneyd Gunay
Cuneyd Gunay
MPMurad Pepe
Murad Pepe

21 February 2014 in HIP International
Verified
Journal Article
Closed access
HAHakan Atalar
Hakan Atalar
CGCuneyd Gunay
Cuneyd Gunay
MKMahmut Komurcu
Mahmut Komurcu
Objective: Developmental dysplasia of the hip (DDH) is a deformity that may cause to serious disability. Early diagnosis and early treatment are very important. Our aim is to report the outcomes of infants with DDH who were treated with the Tübingen hip flexion splint. Materials and methods: Retrospectively, 49 patients (45 female, four male; 60 hips) diagnosed with DDH were included in the study. For diagnosis, all patients underwent ultrasonography of the hip performed according to the Graf method. Infants whose hips were Graf type 2b or worse underwent orthotic treatment. Treatment success was defined as development into a mature hip (Graf type 1 on ultrasonography and no acetabular dysplasia apparent on the latest radiograph). Results: Overall median age at the start of treatment was 18 weeks (14-25). Median total treatment time (from initial application of the splint to the end of weaning) was 17 weeks (14-20). Median duration of follow up was 13.5 months (8.5-31.5). Treatment was successful in 56/60 hips (93.3%). Of the 56 successfully treated patients, acetabular dysplasia was present early in follow up but later resolved in 4 patients. No complications were encountered in any patients in the study. Conclusion: The Tübingen splint provides abduction, but due to its different design it offers the advantages of preventing hip adduction and leaving the knee and ankle joints free. Our findings suggest that in infants with DDH, the Tübingen hip flexion splint is an effective form of treatment.

1 December 2007
Verified
Journal Article
Closed access
YSYener Saglik
Yener Saglik
HAHakan Atalar
Hakan Atalar
YYYusuf Yildiz
Yusuf Yildiz
KBKerem Basarir
Kerem Basarir
CGCuneyd Gunay
Cuneyd Gunay

27 November 2018 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
MYMurat Yegen
Murat Yegen
HAHakan Atalar
Hakan Atalar
CGCuneyd Gunay
Cuneyd Gunay
OYOsman Yuksel Yavuz
Osman Yuksel Yavuz
IUIsmail Uras
Ismail Uras
AKAhmet Yigit Kaptan
Ahmet Yigit Kaptan

1 January 2015 in Journal of Orthopaedic Science
Verified
Journal Article
Open access
DCDeniz CANKAYA
Deniz CANKAYA
YTYalcin Tabak
Yalcin Tabak
AOAkif Muhtar Ozturk
Akif Muhtar Ozturk
CGCuneyd Gunay
Cuneyd Gunay
Background: Many factors affect implant stability and periprosthetic bone mineral density (BMD) following total joint arthroplasty. We asked whether perioperative alendronate, risedronate, calcitonin and indomethacine administration altered (1) femoral stem shear strength and periprosthetic bone mineral density BMD in ovariectomized rats and (2) whether there were differences in the effect of these drugs. Methods: Thirty overiectomized rats were divided into five groups and implanted with intramedullary mini-cortical screws in the femur. Four groups were treated with alendronate, risedronate, salmon calcitonin and indomethacin for 4 weeks preoperatively and 8 weeks postoperatively. Results: Although alendronate and risedronate increased the periprosthetic BMD more than calcitonin, they did not alter implant fixation compared to calcitonin. Indomethacin significantly decreased the BMD around the stem and implant stability compared to all other groups. Conclusions: This study showed that perioperative treatment with bisphosphonates and calcitonin improved the BMD around the stems and implant stability. Although bisphosphonates increased the BMD more than calcitonin, there was no difference in implant stability. Indomethacin markedly decreased the periprosthetic BMD and implant stability. The main clinical significance of our study was the finding about the need to strictly avoid long-term use of high-dose nonsteroidal antiinflammatory drugs for patients who have major joint arthritis and a previous history of arthroplasty.